Filing Details
- Accession Number:
- 0001181431-14-004323
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-29 20:31:59
- Reporting Period:
- 2014-01-27
- Filing Date:
- 2014-01-29
- Accepted Time:
- 2014-01-29 20:31:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1497253 | Organovo Holdings Inc. | ONVO | Biological Products, (No Disgnostic Substances) (2836) | 271488943 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1548912 | Michael Renard | 6275 Nancy Ridge Drive, Suite 110 San Diego CA 92121 | Evp Of Commercial Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-27 | 10,000 | $1.65 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-27 | 10,000 | $8.92 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-01-29 | 30,000 | $1.65 | 30,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-29 | 30,000 | $9.93 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-27 | 10,000 | $0.00 | 10,000 | $1.65 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-29 | 30,000 | $0.00 | 30,000 | $1.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 590,000 | 2022-07-23 | No | 4 | M | Direct | |
| 560,000 | 2022-07-23 | No | 4 | M | Direct |
Footnotes
- The sale of shares was effecutated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $8.90 to $8.95. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.80 to $10.00. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This number does not include 660,000 shares of common stock underlying outstanding options held by Mr. Renard; post-transaction Mr. Renard continues to beneficially own or have a right to acquire 660,000 shares of common stock.
- 25% of the option shares vest and become exercisable on April 30, 2013 and the remaining shares vest in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
